Search Results - "Contieri R"

Microstructural Evolution of Ti–2.5Cu Alloys Produced by Powder Metallurgy and Laser Powder Bed Fusion.

Authors: Terceiro, P. M. Leão, L. A. Rodrigues, J. F. Q. et al.

Source: Metallurgical & Materials Transactions. Part A; Apr2025, Vol. 56 Issue 4, p1449-1460, 12p

Comment on: ALBAN (GETUG-AFU 37): a phase III, randomized, open-label, international trial of intravenous atezolizumab and intravesical Bacillus Calmette-Guérin (BCG) versus BCG alone in BCG-naive high-risk, non-muscle-invasive bladder cancer (NMIBC)

Authors: Contieri, R. Mollica, V. Shariat, S.F. et al.

Source: Annals of Oncology. May2026, Vol. 37 Issue 5, p747-749. 3p.

A0354 - Towards defining follow-up strategies for patients with primary (first diagnosis) EAU2021 intermediate-risk non-muscle invasive bladder cancer.

Authors: Contieri, R. Beijert, I. Martini, A. et al.

Source: European Urology. 2024 Supplement 1, Vol. 85, pS1164-S1165. 2p.

P276 - Replacing ReTUR with Cystoscopy in High-Grade T1 NMIBC patients: Confirmatory results from the HuNIRe Trial.

Authors: Finocchiaro, A. Contieri, R. Casale, P. et al.

Source: European Urology. 2024 Supplement 1, Vol. 85, pS381-S382. 2p.

Microstructural and Mechanical Characterization of Directionally Solidified Conventional and Nb-Modified Mar-M247 Superalloy.

Authors: Costa, A. M. S. Lopes, E. S. N. Contieri, R. J. et al.

Source: Journal of Materials Engineering & Performance; Apr2019, Vol. 28 Issue 4, p2427-2438, 12p

Correction to: Laser Additive Manufacturing of Magnetic Materials.

Authors: Mikler, C. Chaudhary, V. Borkar, T. et al.

Source: JOM: The Journal of The Minerals, Metals & Materials Society (TMS); Dec2017, Vol. 69 Issue 12, p2855-2856, 2p

A1227 - Development of a microultrasound-based nomogram to predict extracapsular extension in patients with prostate cancer undergoing robot-assisted radical prostatectomy.

Authors: Frego, N. Contieri, R. Fasulo, V. et al.

Source: European Urology. Feb2023:Supplement 1, Vol. 83, pS1780-S1781. 2p.

A0722 - Bacillus calmette-guerin vs immediate radical cystectomy in eau defined very high-risk non-muscle invasive bladder cancer patients.

Authors: Contieri, R. Hensley, P. Grajales, V. et al.

Source: European Urology. Feb2023:Supplement 1, Vol. 83, pS1023-S1024. 2p.

A0611 - Implementing the Active Surveillance (AS) follow-up schedule for low-grade Non- Muscle-Invasive Bladder Cancer (NMIBC) tumors.

Authors: Contieri, R. Martini, A. Beatrici, E. et al.

Source: European Urology. Feb2023:Supplement 1, Vol. 83, pS870-S871. 2p.

A0742 - The international bladder cancer group intermediate-risk non-muscle invasive bladder cancer (IBCG IR-NMIBC) scoring system predicts the need for intervention for patients on active surveillance.

Authors: Contieri, R. Tan, W.S. Buffi, N.M. et al.

Source: European Urology. 2024 Supplement 1, Vol. 85, pS1717-S1717. 1p.

V003 - Negative predictive value of intraoperative fluorescence-guided surgery of PSMA - positive prostate cancer during prostatectomy.

Authors: Contieri, R. de Barros, H.A. Stibbe, J.A. et al.

Source: European Urology. 2024 Supplement 1, Vol. 85, pS540-S540. 1p.

A0607 - T1 substaging is associated with worse oncological outcomes for patients treated with Bacillus Calmette-Guerin or immediate radical cystectomy.

Authors: Contieri, R. Tan, W.S. Grajales, V. et al.

Source: European Urology. Feb2023:Supplement 1, Vol. 83, pS865-S865. 1p.

A0231 - Prospective validation of the ROL system in substaging pT1 high-grade bladder cancer: A confirmatory progression risk analysis to ease decision making.

Authors: Valeri, M. Contieri, R. Fasulo, V. et al.

Source: European Urology. 2022 Supplement 1, Vol. 81, pS362-S362. 1p.

A0854 - Consistencies in follow-up after radical cystectomy for bladder cancer: A practice-based framework by collaborative EAU bladder cancer guideline panels.

Authors: Mertens, L.S. Bruins, H.M. Contieri, R. et al.

Source: European Urology. 2024 Supplement 1, Vol. 85, pS1887-S1888. 2p.

Laser additive processing of a functionally graded internal fracture fixation plate.

Authors: Lima, D.D. Mantri, S.A. Mikler, C.V. et al.

Source: Materials & Design. Sep2017, Vol. 130, p8-15. 8p.

A0278 - Machine learning-based survival model optimizes the outcome prediction in high-grade T1 bladder carcinoma: Improving selection of suitable candidates for timely radical cystectomy.

Authors: Subiela Henriquez, J.D. Krajewski, W. Gonzalez-Padilla, D.A. et al.

Source: European Urology. Feb2023:Supplement 1, Vol. 83, pS399-S400. 2p.

A0682 - A novel multi-imaging based focal therapy program for prostate cancer with high intensity focused ultrasound: Early oncological outcomes of a single-center experience.

Authors: Maffei, D. Fasulo, V. Moretto, S. et al.

Source: European Urology. 2024 Supplement 1, Vol. 85, pS1637-S1637. 1p.

P328 - What happens to patients with a PI-RADS 5 lesion and a negative prostate biopsy? Long term follow up of a single institutional experience.

Authors: Paciotti, M. Cella, L. Maffei, D. et al.

Source: European Urology. 2024 Supplement 1, Vol. 85, pS454-S454. 1p.

A0057 - Clinical and high-resolution micro-ultrasound risk factors for detecting clinically significant prostate cancer in men with PI-RADS 3 lesions: Update from a large single center experience.

Authors: Avolio, P.P. Fasulo, V. Maffei, D. et al.

Source: European Urology. Feb2023:Supplement 1, Vol. 83, pS84-S84. 1p.

A0657 - External validation and comparison of two nomograms predicting the probability of lymph node involvement in patients subjected to robotic radical prostatectomy and concomitant lymph node dissection.

Authors: Frego, N. Paciotti, M. Avolio, P.P. et al.

Source: European Urology. 2022 Supplement 1, Vol. 81, pS987-S987. 1p.